... EM , de Filippi CR . Echocardiography in the cardiac transplant recipient . Heart Fail Clin 2007 ; 3 : 51 – 67 . 11 Badano LP , Miglioranza MH , Edvardsen T , Colafranceschi AS , Muraru D , Bacal F , et al European association of Cardiovascular...

... sounds, no rales, or wheezing noted’. A 67-year-old female with a prior history of cardiac transplant 1 year prior, on an immunosuppressant regimen, presented to University Medical Center (UMC) with worsening shortness of breath. Her symptoms of fever, headaches, and myalgias had started 6 days prior...

... of the complement system. Cardiac transplantation Antibody-mediated rejection Immunomodulation Case report Learning points Antibody-mediated rejection (AMR) in cardiac transplantation is difficult to diagnose. Treatments for AMR are broad spectrum in approach. Clinical response guides therapy better...

... manifestations, subsequent genetic testing revealed an X-linked dystrophin gene mutation [c.31+G>T (IVS1G>T)]. He was commenced on empirical heart failure therapy and underwent successful cardiac transplantation. Discussion  X-linked dilated cardiomyopathy is a rare, rapidly progressing cardiomyopathy...

... sequences: LNA Scr 5′ ACGTCTATACGCCCA 3′  LNA 21 5′ TCAGTCTGATAAGCT 3′ Abstract Aims Cardiac transplantation is the only curative therapy for end-stage heart failure. Fibrosis is one of the major causes for impaired function of cardiac allografts. MicroRNAs, a class of small non-coding RNAs, play...

...: [email protected] 2011 Abstract Aims Cardiac allograft vasculopathy (CAV) is a major cause of morbidity and mortality in cardiac transplant recipients. This study evaluates the usefulness of single photon emission computed tomography (SPECT) and various SPECT-derived diastolic variables to detect CAV...

... following cardiac transplantation to assess for acute rejection, particularly in the first 12 months following transplantation. ^1–3 It is also used to investigate certain cardiomyopathic processes, including acute myocarditis, infiltrative and restrictive disorders (such as amyloidosis...

...Sudhir S. Kushwaha; Eugenia Raichlin; Yuri Sheinin; Walter K. Kremers; Krishnaswamy Chandrasekaran; Gregory J. Brunn; Jeffrey L. Platt LVH occurs frequently in cardiac transplants and adversely affects survival. ⁷ In this setting cardiac hypertrophy contributes to diastolic...

... are potent agents for the suppression of chronic rejection because they are critically involved in the suppression of proinflammatory signaling pathways. Cardiac transplantation Rejection Artery Inflammation Polyphenol Mice Cardiac transplantation has been established in humans, however acute rejection...

... and the outcome achieved are discussed. cardiac transplantation atrial flutter atrial tachycardia ablation suture line Conduction of the native sinus rhythm across the suture line to the donor heart occurs in up to 10% of patients following orthotopic cardiac transplantation. Conduction of atrial arrhythmias...

... 2004 Allograft vasculopathy Aortic allograft Cardiac transplantation Chronic rejection CD8⁺ T lymphocytes Perforin Granzyme Interferon-gamma The cellular and molecular mechanisms involved in the generation of AV are not known. It is known that AV is a T-cell-mediated phenomenon...

... coagulopathy resulted in the removal of one patient from the transplant list during this time. Four patients developed sepsis, resulting in two more patients being removed from the transplant list. Of the seven patients (35%) who received a cardiac transplant, the waiting period on the VAD ranged from 9.88...

...R.S. Gardner; F. Özalp; A.J. Murday; S.D. Robb; T.A. McDonagh The aims of this study were firstly to evaluate the prognostic value of NT-proBNP in patients with advanced heart failure referred for consideration of cardiac transplantation, and secondly to compare the prognostic ability of NT-proBNP...

...N.D. Holt; K. Hetherington; S. Brady; J.H. Dark; J.M. McComb Europace (1999) 1, 187–191 Electrophysiological properties of the recipient atrial remnant after human orthotopic cardiac transplantation N. D. Holt, K. Hetherington, S...

...H. Douard; E. Parrens; M. A. Billes; L. Labbe; E. Baudet; J. P. Broustet Correspondence: H. Douard, Hôpital Cardiologique du Haut Lévèque, 33604 Pessac, France 03 4 1997 11 4 1997 © 1997 The European Society of Cardiology 1997 Abstract Exercise capacity in cardiac transplanted...

...A. N. Abdallah; M. A. Billes; Y. Attia; C. Doutremepuich; A. Cassaigne; A. Iron Cardiac transplantation heart-graft rejection tumour necrosis factor alpha interleukin-6 Correspondence: Dr A. Iron. Département de Biochimie Médicale et Biologie Moléculaire, Université de Bordeaux 2, 146...

... of acetylcholine (ACh 50μg and 100μg i.e.), nitroglycerin (0.3 mg i.e.) and dipyridamole (0.56mg. kg⁻¹ i.v.) in 17 patients (3 female114 male; age: 47±3.6 years) with angiographically normal coronary arteries 40 ± 51 months after cardiac transplantation. The effect of ACh on large conduit arteries...

..., myocardial perfusion evaluated with exercise thallium 201 SPECT is usually normal despite a high frequency of myocardial hypertrophy. Cardiac transplantation Thallium-201 scintigraphy echocardiography European Heart Journal (1994) 15, 1119-1123 Thallium perfusion and myocardial hypertrophy...

.... Furthermore, recording of abnormal late potentials are associated both with acute rejection after cardiac transplantation and unsuccessful thrombolytic therapy after myocardial infarction. Interestingly, antiarrhytmic drugs have no clear effect on cardiac late potentials. Cardiac late potential signal...

... and circulating BNP levels in paediatric cardiac transplant recipients, over a three year period after transplantation. Methods: Total RNA extracted from endomyocardial right ventricular biopsy tissues (n = 26) of 13 cardiac transplant recipients (age range 5-17 years) and 10 normal hearts obtained at necropsy...